コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nks to hydroxyproline through the galactose (galactosylation).
2 of three IgGs, yielding 80.2-96.3% terminal galactosylation.
3 terminal sialylation, which is dependent on galactosylation.
4 f gene mutations that affect sialylation and galactosylation.
5 a configuration suspected to prevent beta1,3 galactosylation.
6 The epimerase is required for glycoprotein galactosylation.
7 considerable variation in the extent of LPG galactosylation.
8 , but which maintains normal levels of Golgi galactosylation.
9 ia ni TN-5B1-4 cells are capable of terminal galactosylation.
10 ontain LeX antigens that are masked by alpha-galactosylation.
11 ing group providing the most alpha-selective galactosylations.
12 ance to bacteriophage predation and that LTA galactosylation alters L. lactis resistance to bacterioc
13 ting antenna can be converted into LacNAc by galactosylation and can then be enzymatically modified i
14 t correlation between levels of aberrant IgG galactosylation and disease activity (Spearman's rho = 0
17 tween a donor substrate and acceptor in both galactosylation and N-acetylglucosaminylation, since a c
18 whilst long-term IgG Abs have low levels of galactosylation and sialylation and are most likely gene
20 e 352 allele to be associated with decreased galactosylation and sialylation of apolipoprotein B100,
21 e (F241A, F243A, V262E, and V264E) increased galactosylation and sialylation of the Fc and, concomita
24 d GN to define the relative contributions of galactosylation and sialylation, in relation to cryoglob
25 -protein interactions, rather than increased galactosylation and sialylation, modifies the Fc conform
30 ble to distinguish differences in bisection, galactosylation, and sialylation in N-glycans derived fr
31 filing revealed a loss of core fucosylation, galactosylation, and sialylation in patient samples.
32 pressed in an Arabidopsis mutant lacking XyG galactosylation, and two of them resulted in the product
36 Cavities on the RiCE17 surface may accept galactosylations at the C6 positions of mannose adjacent
39 Acetyl groups at C4 ensure alpha-selective galactosylations by forming a covalent bond to the anome
42 ucosylation (tri-, core, and outer arm), and galactosylation (di-, tri-, and tetra-) between striatum
44 ered noncontiguous Hyp residues are sites of galactosylation, giving rise to the arabinogalactan hete
47 ed that biantennary oligosaccharides lacking galactosylation had slightly faster clearance rates than
49 tematically examined the requirement for WTA galactosylation in a mouse oral-virulent strain by first
53 The result is that the rate constant for galactosylation is increased but degalactosylation is sl
54 both core alpha1,6-fucosylation and beta1,4-galactosylation is the presence of a nonreducing termina
55 antibody displayed lower levels of terminal galactosylation leading to reduced asialoglycoprotein-re
57 t oligoarabinosides (Hyp-arabinosides) while galactosylation leads to the addition of larger arabinog
62 ing antibodies (IgGs) characterized by lower galactosylation levels of the IgG fragment crystallizabl
66 suggest that targeted modulation of protein galactosylation may represent a therapeutic approach to
67 h grants selective detection of sialylation, galactosylation, N-acetylglucosaminylation, and fucosyla
68 tance to both hexosaminidase and to in vitro galactosylation, O-GlcNAc moieties appear to be largely
72 oups led to excellent stereocontrol of alpha-galactosylation of a variety of glycosyl acceptors with
76 e Golgi, (ii) secretion from the cell, (iii) galactosylation of chondroitin sulfate (CS) chains, (iv)
77 abinosylation of contiguous Hyp residues and galactosylation of clustered noncontiguous Hyp residues.
78 etylglucosamine was abolished, the degree of galactosylation of core alpha1,6-fucose increased, and a
80 tion of the GPI precursor lipid or defective galactosylation of GPI intermediates in the endoplasmic
83 ogether, these results strongly suggest that galactosylation of I-branch is a rate-limiting step in I
85 ylation of the hydroxyproline residues and O-galactosylation of interspersed serine residues create a
90 cells is accompanied by an increase in alpha-galactosylation of membrane glycoproteins and a decrease
91 beta4GalT-6 contributes only slightly to the galactosylation of N-glycans and is also not involved in
92 herefore, beta4GalT-1 is a key enzyme in the galactosylation of N-glycans, but is not involved in gly
96 l elongation appears to be slightly reduced, galactosylation of the XyGs is not strictly required for
97 lytic anemia, we defined the contribution of galactosylation or sialylation to the pathogenic activit
98 ted that sialic acid modifications, alpha1-3-galactosylation, or sulfation did not mask epitopes for
100 ity, and we propose that strain-specific LPG galactosylation patterns reflect differences in their ex
101 Although capping the beta-GlcNAc moieties by galactosylation prevents clearance of short-term-cooled
102 galactosyltransferase is used to enhance the galactosylation profile of three IgGs, yielding 80.2-96.
104 ements of etiolated hypocotyls revealed that galactosylation rather than fucosylation of the side cha
107 ved in complex N-linked glycan formation and galactosylation, respectively, were reflected by increas
108 e cells, indicating that galactosyl(alpha1-3)galactosylation sensitizes these viruses as well as mamm
109 belong to three main glycosylation features: galactosylation, sialylation, and level of bisecting N-a
112 revious in vitro studies have shown that the galactosylation status of laminin directly influences it
113 ngineered by MAGTs reveal that the degree of galactosylation strongly affects the interaction with ce
116 IgG-Fc glycoform with fucosylation and fully galactosylation was an independent factor for a total Kn
117 on, and C-reactive protein level on aberrant galactosylation was determined using multivariate analys
118 N-acetylglucosamine at the nonreducing ends, galactosylation was judged to be inefficient, prompting
120 of IgA1, probably taking the form of reduced galactosylation, was confirmed in IgAN in this study.
122 ted galactosyltransferase produces efficient galactosylation when uridine diphosphate-galactose is ad
123 to the production of platelets with aberrant galactosylation, which in turn promote hepatic TPO synth
124 ith N-glycolyl neuraminic acid and extent of galactosylation (zero-, mono-, di-, and alpha(1-3)-galac